Answer
Sivextro (tedizolid phosphate) is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1.
Sources for this answer
- Sivextro 200 mg powder for concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.3 Contraindications · Version 15Document updated
Sources checked